Literature DB >> 21577210

Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.

M I Rodríguez1, A González-Flores, F Dantzer, J Collard, A G de Herreros, F J Oliver.   

Abstract

Snail1 is a master regulator of the epithelial-mesenchymal transition (EMT) and has been implicated in key tumor biological processes such as invasion and metastasis. It has been previously shown that poly(ADP-ribose) polymerase-1 (PARP-1) knockdown, but not PARP inhibition, downregulates the expression of Snail1. In this study we have characterized a novel regulatory mechanism controlling Snail1 protein expression through poly(ADP-ribosyl)ation. The effect is not only limited to repression of Snail1 transcription but also to downregulated Snail1 protein stability. PARP-1 (but not PARP-2) poly(ADP) ribosylates Snail1, both in vivo and in vitro, and interacts with Snail1, an association that is sensitive to PARP inhibitors. PARP inhibition has also clear effects on EMT phenotype of different tumor cells, including Snail1 downregulation, E-cadherin upregulation, decreased cell elongation and invasiveness. Therefore, this study reveals a new regulatory mechanism of Snail1 activation through poly(ADP-ribosyl)ation with consequences in malignant transformation through EMT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21577210     DOI: 10.1038/onc.2011.153

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

Review 1.  Regulation of the protein stability of EMT transcription factors.

Authors:  V M Díaz; R Viñas-Castells; A García de Herreros
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

2.  HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals.

Authors:  Panpan An; Feng Chen; Zihan Li; Yuyi Ling; Yanxi Peng; Haisheng Zhang; Jiexin Li; Zhuojia Chen; Hongsheng Wang
Journal:  Oncogene       Date:  2020-06-04       Impact factor: 9.867

Review 3.  BERing the burden of damage: Pathway crosstalk and posttranslational modification of base excision repair proteins regulate DNA damage management.

Authors:  Kristin L Limpose; Anita H Corbett; Paul W Doetsch
Journal:  DNA Repair (Amst)       Date:  2017-06-09

Review 4.  DNA damage response genes and the development of cancer metastasis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

5.  Doxorubicin enhances Snail/LSD1-mediated PTEN suppression in a PARP1-dependent manner.

Authors:  Yiwei Lin; Tiebang Kang; Binhua P Zhou
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

6.  PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair.

Authors:  E-B Choi; A-Y Yang; S C Kim; J Lee; J K Choi; C Choi; M-Y Kim
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

7.  Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.

Authors:  Xiang Zhao; Dan Li; Dandan Huang; Huajie Song; Hong Mei; Erhu Fang; Xiaojing Wang; Feng Yang; Liduan Zheng; Kai Huang; Qiangsong Tong
Journal:  Mol Ther       Date:  2017-12-22       Impact factor: 11.454

8.  PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis.

Authors:  Hong Pu; Craig Horbinski; Patrick J Hensley; Emily A Matuszak; Timothy Atkinson; Natasha Kyprianou
Journal:  Carcinogenesis       Date:  2014-08-30       Impact factor: 4.944

Review 9.  Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors.

Authors:  José Yélamos; Miguel Galindo; Judith Navarro; Joan Albanell; Ana Rovira; Federico Rojo; Javier Oliver
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

10.  Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1.

Authors:  Biao Hu; Zhe Wu; Polla Hergert; Craig A Henke; Peter B Bitterman; Sem H Phan
Journal:  Am J Pathol       Date:  2013-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.